From all these potentially pathogenic peptides, the strongest activating bacterial ligand tested was the SLPRLFPLL peptide derived from Klebsiella oxytoca (30,000 times more potent than the natural PPI peptide), leading to a model for molecular mimicry as a driver for CD8+ T cell response in T1D (Figure 1). Here, CD8A is linked to type 1 diabetes mellitus.